In contrast to that for amyloid PET, the positive predictive value of FTP tau PET in patients with MCI or dementia is high, whereas the negative predictive value is uncertain, especially in older patients who may develop impairment at lower levels of tau pathology. This evidence concerns the gene MAPT and dementia.